BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21474403)

  • 21. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects.
    Kim KS; Kim SK; Lee YK; Park SW; Cho YW
    Diabet Med; 2008 Aug; 25(8):997-1000. PubMed ID: 18959616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between glycated hemoglobin and glucose concentrations in the adult Galician population: selection of optimal glycated hemoglobin cut-off points as a diagnostic tool of diabetes mellitus.
    Botana López MA; López Ratón M; Tomé MA; Fernández Mariño A; Mato Mato JA; Rego Iraeta A; Pérez Fernández R; Cadarso Suárez C
    Endocrinol Nutr; 2012 Oct; 59(8):496-504. PubMed ID: 22857908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
    Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
    Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.
    Doerr R; Hoffmann U; Otter W; Heinemann L; Hunger-Battefeld W; Kulzer B; Klinge A; Lodwig V; Amann-Zalan I; Sturm D; Tschoepe D; Spitzer SG; Stumpf J; Lohmann T; Schnell O
    Diabetologia; 2011 Nov; 54(11):2923-30. PubMed ID: 21773683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of glycated haemoglobin (HbA1c) as a screening test for diabetes and impaired glucose tolerance (IGT) in a high risk population--the Brazilian Xavante Indians.
    Franco LJ; Dal Fabbro AL; Martinez EZ; Sartorelli DS; Silva AS; Soares LP; Franco LF; Kuhn PC; Vieira-Filho JP; Moisés RS
    Diabetes Res Clin Pract; 2014 Nov; 106(2):337-42. PubMed ID: 25271115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemoglobin A(1c) measurement for diabetes among subjects with a previous history of impaired glucose tolerance.
    Qiao Q; Keinänen-Kukaanniemi ; Kivelä SL
    Diabetes Res Clin Pract; 1995 Dec; 30(3):189-94. PubMed ID: 8861458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
    Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
    Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.
    Prakaschandra R; Naidoo DP
    Ethn Dis; 2018; 28(1):19-24. PubMed ID: 29467562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.
    Park KS; Park YJ; Kim SW; Shin CS; Park DJ; Koh JJ; Kim SY; Kim NK; Lee HK
    Korean J Intern Med; 2000 Jan; 15(1):37-41. PubMed ID: 10714090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension?
    Bur A; Herkner H; Woisetschläger C; Vlcek M; Derhaschnig U; Hirschl MM
    Am J Hypertens; 2003 Apr; 16(4):297-301. PubMed ID: 12670746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.
    Yip WCY; Sequeira IR; Plank LD; Poppitt SD
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29165385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
    Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
    Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose.
    Tatsch E; Bochi GV; Piva SJ; Pereira RS; Kober H; De Carvalho JA; Sangoi MB; Duarte MM; Moresco RN
    Clin Lab; 2012; 58(3-4):347-50. PubMed ID: 22582512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.
    Kharroubi AT; Darwish HM; Abu Al-Halaweh AI; Khammash UM
    PLoS One; 2014; 9(2):e88123. PubMed ID: 24505401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes.
    Tankova T; Chakarova N; Dakovska L; Atanassova I
    Acta Diabetol; 2012 Oct; 49(5):371-8. PubMed ID: 21964885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.